Protara Therapeutics, Inc. (TARA) Operating cash flow 2016–2025
Protara Therapeutics, Inc. (TARA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$56.4MFY2025 · since FY2016: -$23.7M → -$56.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$56.4M | -57.4% |
| FY2024 | -$35.8M | +4.7% |
| FY2023 | -$37.6M | -42.0% |
| FY2022 | -$26.5M | +23.3% |
| FY2021 | -$34.5M | -47.4% |
| FY2020 | -$23.4M | -367.1% |
| FY2019 | -$5.0M | +78.4% |
| FY2018 | -$23.2M | -3.9% |
| FY2017 | -$22.4M | +5.6% |
| FY2016 | -$23.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice